Biolegend, 581816, Cell-Vive™ GMP Recombinant Human IL-33 (carrier-free)
100microg
Catalog Number: 581816
Send an RFQ.
Category
Loading…
| Source | Human IL-33, amino acids Ser112-Thr270 (Accession# NM_ 033439) was expressed in E. coli. |
|---|---|
| Molecular Mass | The 159 amino acid recombinant protein has a predicted molecular mass of approximately 18 kD. The DTT-reduced protein migrates at approximately 19 kD and non-reduced protein migrates at approximately 20 kD by SDS-PAGE. The N-terminal amino acid is Serine. |
| N-terminalSequence Analysis | Ser-Ile-Thr-Gly-Ile-Ser-Pro-Ile-Thr-Glu |
| Purity | ≥ 95%, as determined by Coomassie stained SDS-PAGE |
| Formulation | 0.1 µm filtered protein solution is in PBS, 1 mM EDTA, 2 mM TCEP |
| Endotoxin Level | Less than or equal to 0.1 EU per μg protein as determined by the LAL method |
| Residual Host Cell Protein Content | ≤ 0.500 ng/μg by ELISA |
| Concentration | 500 µg/mL |
| Storage & Handling | Unopened vial can be stored between 2°C and 8°C for up to 2 weeks, at -20°C for up to six months, or at -70°C or colder until the expiration date. For maximum results, quick spin vial prior to opening. The protein can be aliquoted and stored at -20°C or colder. Stock solutions can also be prepared at 50 - 100 µg/mL in appropriate sterile buffer, carrier protein such as 0.2 - 1% endotoxin-free BSA or HSA can be added when preparing the stock solution. Aliquots can be stored between 2°C and 8°C for up to one week or stored at -20°C or colder for up to 3 months. Avoid repeated freeze/thaw cycles. |
Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:
Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.
| Activity | ED50 = 0.1 - 0.5 ng/mL as determined by the dose-dependent stimulation of D10.G4.1 cell proliferation. Deep Blue Cell Viability™ Kit (Cat. No. 424701) is used to measure the proliferation. |
|---|
| Application | Bioassay Cell Culture |
|---|
| Application Notes | BioLegend carrier-free recombinant proteins provided in liquid format are shipped on blue-ice. Our comparison testing data indicates that when handled and stored as recommended, the liquid format has equal or better stability and shelf-life compared to commercially available lyophilized proteins after reconstitution. Our liquid proteins are validated in-house to maintain activity after shipping on blue ice and are backed by our 100% satisfaction guarantee. If you have any concerns, contact us at [email protected]. |
|---|
| Disclaimer | BioLegend Cell-Vive™ GMP Recombinant proteins are for research use only. Suitable for ex vivo cell processing. Not for injection or diagnostic or therapeutic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products. |
|---|
| Structure | Cytokine |
|---|
| Distribution | IL-33 mRNA is expressed in a broad range of human tissues, such as heart, small intestine, brain, ovary, testis, pancreas, and colon. Higher IL-33 expression was detected in human keratinocyte, fibroblast, myocyte, and alveolar cells |
|---|
| Function | IL-33 drives production of Th2-associated cytokines from in vitro polarized Th2 cells. In mice, IL-33 injection induced the expression of IL-4, IL-5, and IL-13 and led to severe pathological changes in the lung and the digestive tract. In addition, IL-33 acts as a chemoattractant for Th2 cells, both in vitro and in vivo. TNF-α and IL-1β are activators of IL-33 transcription in fibroblasts and keratinocytes. |
|---|
| Interaction | Th2 cells, mast cells, basophils, eosinophils and natural killer cells |
|---|
| Ligand/Receptor | IL-1 family receptor T1/ST2 and IL-1RAcP (IL-1 receptor associated protein). |
|---|
| Bioactivity | Measured by its ability to induce proliferation of D10.G4.1 cells. |
|---|
| Biology Area | Cell Biology, Immunology, Stem Cells, Transcription Factors |
|---|
| Molecular Family | Cytokines/Chemokines |
|---|
| Antigen References | Schmitz J, et al. 2005. Immunity. 23:479-90. Barksby HE, et al. 2007. Clin Exp Immunol. 149:217-25. Arend WP, et al. 2008. Immunol Rev. 223:20-38. Suzukawa M, et al. 2008. J Immunol. 181:5981-9. Moussion C, et al. 2008. PLoS One. 3:e3331. Mildner M, et al. 2010. Cardiovasc Res. 87:769-77. |
|---|
| Gene ID | 90865 |
|---|
| UniProt | View information about IL-33 on UniProt.org |
|---|
| Other Names | C9orf26, IL1F11, NFHEV, DVS 27 |
|---|
